Danielle Montt

Danielle Montt is the in-vivo study coordinator at Verve Therapeutics. Ms. Montt has 10 years of experience in science, with 7 of those years in the biotech industry. She has worked in areas such as quality control for the Tdap vaccine, and conducted in vivo ocular research for retinal dystrophy, rare diseases, and severe genetic diseases. For the past 5 years, her primary focus has been in the oncology space, where her responsibilities consisted of the planning, organizing, execution, and management of in vivo studies to support external partnerships, internal programs, and other departments. Cumulatively, Ms. Montt has 4 years of GLP and GMP experience. She received her B.S. in biology, with a concentration in ecological sciences, from Bridgewater State University.